 | • レポートコード：QY2108PAL4068 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は止血パウダーの世界市場の現状について調査・分析し、2027年までの市場を予測しました。止血パウダーの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（吸収性止血剤、非吸収性止血剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・止血パウダーの世界市場概要 ・メーカー別の競争状況、市場シェア ・止血パウダーの種類別市場規模：吸収性止血剤、非吸収性止血剤 ・止血パウダーの用途別市場規模：病院、クリニック、その他 ・北米の止血パウダー市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの止血パウダー市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの止血パウダー市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の止血パウダー市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの止血パウダー市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Johnson & Johnson、BD、Baxter、B.Braun、Cura Medical、GELITA MEDICAL、Curasan AG、Meril Life Sciences、Zhonghui Shengxi、Beijing Datsing Bio-tech、Guizhou Jin Jiu Biotech、Beijing Taikesiman、Foryou Medical、Saikesaisi Holdings Group、Biotemed ・止血パウダーのバリューチェーン・販売チャネル分析 ・止血パウダーの世界市場動向 |
Market Analysis and Insights: Global Hemostatic Powder Market
The global Hemostatic Powder market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Hemostatic Powder Scope and Segment
Hemostatic Powder market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hemostatic Powder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Absorbable Hemostatic Agent
Not Absorbable Hemostatic Agent
Segment by Application
Hospital
Clinics
Other
By Company
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Hemostatic Powder Product Introduction
1.2 Market by Type
1.2.1 Global Hemostatic Powder Market Size Growth Rate by Type
1.2.2 Absorbable Hemostatic Agent
1.2.3 Not Absorbable Hemostatic Agent
1.3 Market by Application
1.3.1 Global Hemostatic Powder Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hemostatic Powder Sales Estimates and Forecasts 2016-2027
2.2 Global Hemostatic Powder Revenue Estimates and Forecasts 2016-2027
2.3 Global Hemostatic Powder Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Hemostatic Powder Regions by Sales
2.4.1 Global Top Hemostatic Powder Regions by Sales (2016-2021)
2.4.2 Global Top Hemostatic Powder Regions by Sales (2022-2027)
2.5 Global Top Hemostatic Powder Regions by Revenue
2.5.1 Global Top Hemostatic Powder Regions by Revenue (2016-2021)
2.5.2 Global Top Hemostatic Powder Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hemostatic Powder Sales by Manufacturers
3.1.1 Global Top Hemostatic Powder Manufacturers by Sales (2016-2021)
3.1.2 Global Top Hemostatic Powder Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Hemostatic Powder Sales in 2020
3.2 Global Hemostatic Powder Revenue by Manufacturers
3.2.1 Global Top Hemostatic Powder Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Hemostatic Powder Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Hemostatic Powder Revenue in 2020
3.3 Global Hemostatic Powder Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hemostatic Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hemostatic Powder Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hemostatic Powder Sales by Type
4.1.1 Global Hemostatic Powder Historical Sales by Type (2016-2021)
4.1.2 Global Hemostatic Powder Forecasted Sales by Type (2022-2027)
4.1.3 Global Hemostatic Powder Sales Market Share by Type (2016-2027)
4.2 Global Hemostatic Powder Revenue by Type
4.2.1 Global Hemostatic Powder Historical Revenue by Type (2016-2021)
4.2.2 Global Hemostatic Powder Forecasted Revenue by Type (2022-2027)
4.2.3 Global Hemostatic Powder Revenue Market Share by Type (2016-2027)
4.3 Global Hemostatic Powder Price by Type
4.3.1 Global Hemostatic Powder Price by Type (2016-2021)
4.3.2 Global Hemostatic Powder Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Hemostatic Powder Sales by Application
5.1.1 Global Hemostatic Powder Historical Sales by Application (2016-2021)
5.1.2 Global Hemostatic Powder Forecasted Sales by Application (2022-2027)
5.1.3 Global Hemostatic Powder Sales Market Share by Application (2016-2027)
5.2 Global Hemostatic Powder Revenue by Application
5.2.1 Global Hemostatic Powder Historical Revenue by Application (2016-2021)
5.2.2 Global Hemostatic Powder Forecasted Revenue by Application (2022-2027)
5.2.3 Global Hemostatic Powder Revenue Market Share by Application (2016-2027)
5.3 Global Hemostatic Powder Price by Application
5.3.1 Global Hemostatic Powder Price by Application (2016-2021)
5.3.2 Global Hemostatic Powder Price Forecast by Application (2022-2027)
6 North America
6.1 North America Hemostatic Powder Market Size by Type
6.1.1 North America Hemostatic Powder Sales by Type (2016-2027)
6.1.2 North America Hemostatic Powder Revenue by Type (2016-2027)
6.2 North America Hemostatic Powder Market Size by Application
6.2.1 North America Hemostatic Powder Sales by Application (2016-2027)
6.2.2 North America Hemostatic Powder Revenue by Application (2016-2027)
6.3 North America Hemostatic Powder Market Size by Country
6.3.1 North America Hemostatic Powder Sales by Country (2016-2027)
6.3.2 North America Hemostatic Powder Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Hemostatic Powder Market Size by Type
7.1.1 Europe Hemostatic Powder Sales by Type (2016-2027)
7.1.2 Europe Hemostatic Powder Revenue by Type (2016-2027)
7.2 Europe Hemostatic Powder Market Size by Application
7.2.1 Europe Hemostatic Powder Sales by Application (2016-2027)
7.2.2 Europe Hemostatic Powder Revenue by Application (2016-2027)
7.3 Europe Hemostatic Powder Market Size by Country
7.3.1 Europe Hemostatic Powder Sales by Country (2016-2027)
7.3.2 Europe Hemostatic Powder Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hemostatic Powder Market Size by Type
8.1.1 Asia Pacific Hemostatic Powder Sales by Type (2016-2027)
8.1.2 Asia Pacific Hemostatic Powder Revenue by Type (2016-2027)
8.2 Asia Pacific Hemostatic Powder Market Size by Application
8.2.1 Asia Pacific Hemostatic Powder Sales by Application (2016-2027)
8.2.2 Asia Pacific Hemostatic Powder Revenue by Application (2016-2027)
8.3 Asia Pacific Hemostatic Powder Market Size by Region
8.3.1 Asia Pacific Hemostatic Powder Sales by Region (2016-2027)
8.3.2 Asia Pacific Hemostatic Powder Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Hemostatic Powder Market Size by Type
9.1.1 Latin America Hemostatic Powder Sales by Type (2016-2027)
9.1.2 Latin America Hemostatic Powder Revenue by Type (2016-2027)
9.2 Latin America Hemostatic Powder Market Size by Application
9.2.1 Latin America Hemostatic Powder Sales by Application (2016-2027)
9.2.2 Latin America Hemostatic Powder Revenue by Application (2016-2027)
9.3 Latin America Hemostatic Powder Market Size by Country
9.3.1 Latin America Hemostatic Powder Sales by Country (2016-2027)
9.3.2 Latin America Hemostatic Powder Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hemostatic Powder Market Size by Type
10.1.1 Middle East and Africa Hemostatic Powder Sales by Type (2016-2027)
10.1.2 Middle East and Africa Hemostatic Powder Revenue by Type (2016-2027)
10.2 Middle East and Africa Hemostatic Powder Market Size by Application
10.2.1 Middle East and Africa Hemostatic Powder Sales by Application (2016-2027)
10.2.2 Middle East and Africa Hemostatic Powder Revenue by Application (2016-2027)
10.3 Middle East and Africa Hemostatic Powder Market Size by Country
10.3.1 Middle East and Africa Hemostatic Powder Sales by Country (2016-2027)
10.3.2 Middle East and Africa Hemostatic Powder Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Johnson & Johnson Hemostatic Powder Product Description
11.1.5 Johnson & Johnson Recent Developments
11.2 BD
11.2.1 BD Corporation Information
11.2.2 BD Overview
11.2.3 BD Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 BD Hemostatic Powder Product Description
11.2.5 BD Recent Developments
11.3 Baxter
11.3.1 Baxter Corporation Information
11.3.2 Baxter Overview
11.3.3 Baxter Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Baxter Hemostatic Powder Product Description
11.3.5 Baxter Recent Developments
11.4 B.Braun
11.4.1 B.Braun Corporation Information
11.4.2 B.Braun Overview
11.4.3 B.Braun Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 B.Braun Hemostatic Powder Product Description
11.4.5 B.Braun Recent Developments
11.5 Cura Medical
11.5.1 Cura Medical Corporation Information
11.5.2 Cura Medical Overview
11.5.3 Cura Medical Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Cura Medical Hemostatic Powder Product Description
11.5.5 Cura Medical Recent Developments
11.6 GELITA MEDICAL
11.6.1 GELITA MEDICAL Corporation Information
11.6.2 GELITA MEDICAL Overview
11.6.3 GELITA MEDICAL Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 GELITA MEDICAL Hemostatic Powder Product Description
11.6.5 GELITA MEDICAL Recent Developments
11.7 Curasan AG
11.7.1 Curasan AG Corporation Information
11.7.2 Curasan AG Overview
11.7.3 Curasan AG Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Curasan AG Hemostatic Powder Product Description
11.7.5 Curasan AG Recent Developments
11.8 Meril Life Sciences
11.8.1 Meril Life Sciences Corporation Information
11.8.2 Meril Life Sciences Overview
11.8.3 Meril Life Sciences Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Meril Life Sciences Hemostatic Powder Product Description
11.8.5 Meril Life Sciences Recent Developments
11.9 Zhonghui Shengxi
11.9.1 Zhonghui Shengxi Corporation Information
11.9.2 Zhonghui Shengxi Overview
11.9.3 Zhonghui Shengxi Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Zhonghui Shengxi Hemostatic Powder Product Description
11.9.5 Zhonghui Shengxi Recent Developments
11.10 Beijing Datsing Bio-tech
11.10.1 Beijing Datsing Bio-tech Corporation Information
11.10.2 Beijing Datsing Bio-tech Overview
11.10.3 Beijing Datsing Bio-tech Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Beijing Datsing Bio-tech Hemostatic Powder Product Description
11.10.5 Beijing Datsing Bio-tech Recent Developments
11.11 Guizhou Jin Jiu Biotech
11.11.1 Guizhou Jin Jiu Biotech Corporation Information
11.11.2 Guizhou Jin Jiu Biotech Overview
11.11.3 Guizhou Jin Jiu Biotech Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Guizhou Jin Jiu Biotech Hemostatic Powder Product Description
11.11.5 Guizhou Jin Jiu Biotech Recent Developments
11.12 Beijing Taikesiman
11.12.1 Beijing Taikesiman Corporation Information
11.12.2 Beijing Taikesiman Overview
11.12.3 Beijing Taikesiman Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Beijing Taikesiman Hemostatic Powder Product Description
11.12.5 Beijing Taikesiman Recent Developments
11.13 Foryou Medical
11.13.1 Foryou Medical Corporation Information
11.13.2 Foryou Medical Overview
11.13.3 Foryou Medical Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Foryou Medical Hemostatic Powder Product Description
11.13.5 Foryou Medical Recent Developments
11.14 Saikesaisi Holdings Group
11.14.1 Saikesaisi Holdings Group Corporation Information
11.14.2 Saikesaisi Holdings Group Overview
11.14.3 Saikesaisi Holdings Group Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Saikesaisi Holdings Group Hemostatic Powder Product Description
11.14.5 Saikesaisi Holdings Group Recent Developments
11.15 Biotemed
11.15.1 Biotemed Corporation Information
11.15.2 Biotemed Overview
11.15.3 Biotemed Hemostatic Powder Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Biotemed Hemostatic Powder Product Description
11.15.5 Biotemed Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Hemostatic Powder Value Chain Analysis
12.2 Hemostatic Powder Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hemostatic Powder Production Mode & Process
12.4 Hemostatic Powder Sales and Marketing
12.4.1 Hemostatic Powder Sales Channels
12.4.2 Hemostatic Powder Distributors
12.5 Hemostatic Powder Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hemostatic Powder Industry Trends
13.2 Hemostatic Powder Market Drivers
13.3 Hemostatic Powder Market Challenges
13.4 Hemostatic Powder Market Restraints
14 Key Findings in The Global Hemostatic Powder Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Hemostatic Powder Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Absorbable Hemostatic Agent
Table 3. Major Manufacturers of Not Absorbable Hemostatic Agent
Table 4. Global Hemostatic Powder Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Hemostatic Powder Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Hemostatic Powder Sales by Region (2016-2021) & (K Units)
Table 7. Global Hemostatic Powder Sales Market Share by Region (2016-2021)
Table 8. Global Hemostatic Powder Sales by Region (2022-2027) & (K Units)
Table 9. Global Hemostatic Powder Sales Market Share by Region (2022-2027)
Table 10. Global Hemostatic Powder Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Hemostatic Powder Revenue Market Share by Region (2016-2021)
Table 12. Global Hemostatic Powder Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Hemostatic Powder Revenue Market Share by Region (2022-2027)
Table 14. Global Hemostatic Powder Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Hemostatic Powder Sales Share by Manufacturers (2016-2021)
Table 16. Global Hemostatic Powder Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Hemostatic Powder Revenue Share by Manufacturers (2016-2021)
Table 18. Hemostatic Powder Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Hemostatic Powder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Hemostatic Powder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Powder as of 2020)
Table 21. Hemostatic Powder Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hemostatic Powder Product Offered
Table 23. Date of Manufacturers Enter into Hemostatic Powder Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hemostatic Powder Sales by Type (2016-2021) & (K Units)
Table 26. Global Hemostatic Powder Sales by Type (2022-2027) & (K Units)
Table 27. Global Hemostatic Powder Sales Share by Type (2016-2021)
Table 28. Global Hemostatic Powder Sales Share by Type (2022-2027)
Table 29. Global Hemostatic Powder Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Hemostatic Powder Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Hemostatic Powder Revenue Share by Type (2016-2021)
Table 32. Global Hemostatic Powder Revenue Share by Type (2022-2027)
Table 33. Hemostatic Powder Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Hemostatic Powder Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Hemostatic Powder Sales by Application (2016-2021) & (K Units)
Table 36. Global Hemostatic Powder Sales by Application (2022-2027) & (K Units)
Table 37. Global Hemostatic Powder Sales Share by Application (2016-2021)
Table 38. Global Hemostatic Powder Sales Share by Application (2022-2027)
Table 39. Global Hemostatic Powder Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Hemostatic Powder Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Hemostatic Powder Revenue Share by Application (2016-2021)
Table 42. Global Hemostatic Powder Revenue Share by Application (2022-2027)
Table 43. Hemostatic Powder Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Hemostatic Powder Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Hemostatic Powder Sales by Type (2016-2021) & (K Units)
Table 46. North America Hemostatic Powder Sales by Type (2022-2027) & (K Units)
Table 47. North America Hemostatic Powder Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Hemostatic Powder Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Hemostatic Powder Sales by Application (2016-2021) & (K Units)
Table 50. North America Hemostatic Powder Sales by Application (2022-2027) & (K Units)
Table 51. North America Hemostatic Powder Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Hemostatic Powder Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Hemostatic Powder Sales by Country (2016-2021) & (K Units)
Table 54. North America Hemostatic Powder Sales by Country (2022-2027) & (K Units)
Table 55. North America Hemostatic Powder Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Hemostatic Powder Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Hemostatic Powder Sales by Type (2016-2021) & (K Units)
Table 58. Europe Hemostatic Powder Sales by Type (2022-2027) & (K Units)
Table 59. Europe Hemostatic Powder Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Hemostatic Powder Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Hemostatic Powder Sales by Application (2016-2021) & (K Units)
Table 62. Europe Hemostatic Powder Sales by Application (2022-2027) & (K Units)
Table 63. Europe Hemostatic Powder Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Hemostatic Powder Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Hemostatic Powder Sales by Country (2016-2021) & (K Units)
Table 66. Europe Hemostatic Powder Sales by Country (2022-2027) & (K Units)
Table 67. Europe Hemostatic Powder Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Hemostatic Powder Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Hemostatic Powder Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Hemostatic Powder Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Hemostatic Powder Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Hemostatic Powder Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Hemostatic Powder Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Hemostatic Powder Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Hemostatic Powder Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Hemostatic Powder Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Hemostatic Powder Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Hemostatic Powder Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Hemostatic Powder Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Hemostatic Powder Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Hemostatic Powder Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Hemostatic Powder Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Hemostatic Powder Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Hemostatic Powder Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Hemostatic Powder Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Hemostatic Powder Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Hemostatic Powder Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Hemostatic Powder Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Hemostatic Powder Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Hemostatic Powder Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Hemostatic Powder Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Hemostatic Powder Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Hemostatic Powder Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Hemostatic Powder Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Hemostatic Powder Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Hemostatic Powder Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Hemostatic Powder Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Hemostatic Powder Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Hemostatic Powder Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Hemostatic Powder Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Hemostatic Powder Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Hemostatic Powder Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Hemostatic Powder Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Hemostatic Powder Revenue by Country (2022-2027) & (US$ Million)
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Major Businesses
Table 107. Johnson & Johnson Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Johnson & Johnson Hemostatic Powder Product
Table 109. Johnson & Johnson Recent Developments
Table 110. BD Corporation Information
Table 111. BD Description and Major Businesses
Table 112. BD Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. BD Hemostatic Powder Product
Table 114. BD Recent Developments
Table 115. Baxter Corporation Information
Table 116. Baxter Description and Major Businesses
Table 117. Baxter Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Baxter Hemostatic Powder Product
Table 119. Baxter Recent Developments
Table 120. B.Braun Corporation Information
Table 121. B.Braun Description and Major Businesses
Table 122. B.Braun Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. B.Braun Hemostatic Powder Product
Table 124. B.Braun Recent Developments
Table 125. Cura Medical Corporation Information
Table 126. Cura Medical Description and Major Businesses
Table 127. Cura Medical Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Cura Medical Hemostatic Powder Product
Table 129. Cura Medical Recent Developments
Table 130. GELITA MEDICAL Corporation Information
Table 131. GELITA MEDICAL Description and Major Businesses
Table 132. GELITA MEDICAL Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. GELITA MEDICAL Hemostatic Powder Product
Table 134. GELITA MEDICAL Recent Developments
Table 135. Curasan AG Corporation Information
Table 136. Curasan AG Description and Major Businesses
Table 137. Curasan AG Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Curasan AG Hemostatic Powder Product
Table 139. Curasan AG Recent Developments
Table 140. Meril Life Sciences Corporation Information
Table 141. Meril Life Sciences Description and Major Businesses
Table 142. Meril Life Sciences Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Meril Life Sciences Hemostatic Powder Product
Table 144. Meril Life Sciences Recent Developments
Table 145. Zhonghui Shengxi Corporation Information
Table 146. Zhonghui Shengxi Description and Major Businesses
Table 147. Zhonghui Shengxi Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 148. Zhonghui Shengxi Hemostatic Powder Product
Table 149. Zhonghui Shengxi Recent Developments
Table 150. Beijing Datsing Bio-tech Corporation Information
Table 151. Beijing Datsing Bio-tech Description and Major Businesses
Table 152. Beijing Datsing Bio-tech Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 153. Beijing Datsing Bio-tech Hemostatic Powder Product
Table 154. Beijing Datsing Bio-tech Recent Developments
Table 155. Guizhou Jin Jiu Biotech Corporation Information
Table 156. Guizhou Jin Jiu Biotech Description and Major Businesses
Table 157. Guizhou Jin Jiu Biotech Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Guizhou Jin Jiu Biotech Hemostatic Powder Product
Table 159. Guizhou Jin Jiu Biotech Recent Developments
Table 160. Beijing Taikesiman Corporation Information
Table 161. Beijing Taikesiman Description and Major Businesses
Table 162. Beijing Taikesiman Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Beijing Taikesiman Hemostatic Powder Product
Table 164. Beijing Taikesiman Recent Developments
Table 165. Foryou Medical Corporation Information
Table 166. Foryou Medical Description and Major Businesses
Table 167. Foryou Medical Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. Foryou Medical Hemostatic Powder Product
Table 169. Foryou Medical Recent Developments
Table 170. Saikesaisi Holdings Group Corporation Information
Table 171. Saikesaisi Holdings Group Description and Major Businesses
Table 172. Saikesaisi Holdings Group Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 173. Saikesaisi Holdings Group Hemostatic Powder Product
Table 174. Saikesaisi Holdings Group Recent Developments
Table 175. Biotemed Corporation Information
Table 176. Biotemed Description and Major Businesses
Table 177. Biotemed Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 178. Biotemed Hemostatic Powder Product
Table 179. Biotemed Recent Developments
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Hemostatic Powder Distributors List
Table 183. Hemostatic Powder Customers List
Table 184. Hemostatic Powder Market Trends
Table 185. Hemostatic Powder Market Drivers
Table 186. Hemostatic Powder Market Challenges
Table 187. Hemostatic Powder Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostatic Powder Product Picture
Figure 2. Global Hemostatic Powder Market Share by Type in 2020 & 2027
Figure 3. Absorbable Hemostatic Agent Product Picture
Figure 4. Not Absorbable Hemostatic Agent Product Picture
Figure 5. Global Hemostatic Powder Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Clinics
Figure 8. Other
Figure 9. Hemostatic Powder Report Years Considered
Figure 10. Global Hemostatic Powder Sales 2016-2027 (K Units)
Figure 11. Global Hemostatic Powder Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hemostatic Powder Revenue 2016-2027 (US$ Million)
Figure 13. Global Hemostatic Powder Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Hemostatic Powder Sales Market Share by Region (2016-2021)
Figure 15. Global Hemostatic Powder Sales Market Share by Region (2022-2027)
Figure 16. North America Hemostatic Powder Sales YoY (2016-2027) & (K Units)
Figure 17. North America Hemostatic Powder Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Hemostatic Powder Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Hemostatic Powder Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Hemostatic Powder Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Hemostatic Powder Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Hemostatic Powder Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Hemostatic Powder Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Hemostatic Powder Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Hemostatic Powder Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Hemostatic Powder Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Hemostatic Powder Revenue in 2020
Figure 28. Hemostatic Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Hemostatic Powder Sales Market Share by Type (2016-2027)
Figure 30. Global Hemostatic Powder Revenue Market Share by Type (2016-2027)
Figure 31. Global Hemostatic Powder Sales Market Share by Application (2016-2027)
Figure 32. Global Hemostatic Powder Revenue Market Share by Application (2016-2027)
Figure 33. North America Hemostatic Powder Sales Market Share by Type (2016-2027)
Figure 34. North America Hemostatic Powder Revenue Market Share by Type (2016-2027)
Figure 35. North America Hemostatic Powder Sales Market Share by Application (2016-2027)
Figure 36. North America Hemostatic Powder Revenue Market Share by Application (2016-2027)
Figure 37. North America Hemostatic Powder Sales Share by Country (2016-2027)
Figure 38. North America Hemostatic Powder Revenue Share by Country (2016-2027)
Figure 39. United States Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Hemostatic Powder Sales Market Share by Type (2016-2027)
Figure 42. Europe Hemostatic Powder Revenue Market Share by Type (2016-2027)
Figure 43. Europe Hemostatic Powder Sales Market Share by Application (2016-2027)
Figure 44. Europe Hemostatic Powder Revenue Market Share by Application (2016-2027)
Figure 45. Europe Hemostatic Powder Sales Share by Country (2016-2027)
Figure 46. Europe Hemostatic Powder Revenue Share by Country (2016-2027)
Figure 47. Germany Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 48. France Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Hemostatic Powder Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Hemostatic Powder Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Hemostatic Powder Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Hemostatic Powder Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Hemostatic Powder Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Hemostatic Powder Revenue Share by Region (2016-2027)
Figure 58. China Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 61. India Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Hemostatic Powder Sales Market Share by Type (2016-2027)
Figure 68. Latin America Hemostatic Powder Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Hemostatic Powder Sales Market Share by Application (2016-2027)
Figure 70. Latin America Hemostatic Powder Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Hemostatic Powder Sales Share by Country (2016-2027)
Figure 72. Latin America Hemostatic Powder Revenue Share by Country (2016-2027)
Figure 73. Mexico Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Hemostatic Powder Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Hemostatic Powder Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Hemostatic Powder Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Hemostatic Powder Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Hemostatic Powder Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Hemostatic Powder Revenue Share by Country (2016-2027)
Figure 82. Turkey Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Hemostatic Powder Revenue (2016-2027) & (US$ Million)
Figure 85. Hemostatic Powder Value Chain
Figure 86. Hemostatic Powder Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
止血ジェルの世界及び中国市場 Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.…- 止血剤の世界及び中国市場 Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. The world's leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Soluti…
- 止血剤・組織封止剤の世界及び中国市場 Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of…
- 止血アナライザーの世界市場 2020年 Market Overview The global Hemostatic Analyzer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hemostatic Analyzer marke…
- 止血鉗子の世界市場 2020年 Market Overview The Hemostatic Forceps market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…